TMEM8B anticorps (N-Term)
Aperçu rapide pour TMEM8B anticorps (N-Term) (ABIN635576)
Antigène
Voir toutes TMEM8B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- C9 ORF127 antibody was raised against the N terminal Of C9 rf127
-
Purification
- Affinity purified
-
Immunogène
- C9 ORF127 antibody was raised using the N terminal Of C9 rf127 corresponding to a region with amino acids MNMPQSLGNQPLPPEPPSLGTPAEGPGTTSPPEHCWPVRPTLRNELDTFS
-
-
-
-
Indications d'application
-
WB: 1 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
C9ORF127 Blocking Peptide, (ABIN5612544), is also available for use as a blocking control in assays to test for specificity of this C9ORF127 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C0 RF127 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- TMEM8B (Transmembrane Protein 8B (TMEM8B))
-
Autre désignation
- C9ORF127
-
Sujet
- The down-regulation of C9orf127 may be closely associated with tumorigenesis and metastasis of colorectal carcinoma. However, it may not contribute to the development and progression of gastric carcinoma.
-
Poids moléculaire
- 37 kDa (MW of target protein)
Antigène
-